AHRQ Report Points To Pharmacogenetic Data Gaps; Offers Some Validation
Executive Summary
A government technology assessment posted earlier this month suggests the need for more data to back up use of genetic testing to drive drug therapy choices, but still validates key associations between gene variants and patient response to certain drugs